AZD9056: Clinical Trials

4 trials of AZD9056, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Withdrawn 1
Phase 21Completed 1

Follow AZD9056: new trials by email Literature Review of AZD9056 trials Research Report on AZD9056

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients
AZD9056, Methotrexate - Rheumatoid Arthritis
Phase 1WithdrawnAstraZeneca122009-05-012010-12-03
A Study to Assess Co-Administered AZD9056 (Steady State) and Simvastatin (Single Dose) in Healthy Volunteers
simvastatin, AZD9056 + simvastatin - Healthy Volunteers
Phase 1CompletedAstraZeneca122008-08-012010-12-02
Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056
AZD9056, Placebo - Rheumatoid Arthritis
Phase 1CompletedAstraZeneca122008-06-012010-12-01
A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)
AZD9056, Etanercept, Placebo - Rheumatoid Arthritis
Phase 2CompletedAstraZeneca3852007-08-012013-02-04

Conditions studied

Arthritis, Rheumatoid (3)

Sponsors

AstraZeneca (4)

Countries

Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Mexico (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Slovakia (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Edward Keystone, MD, FRCPC (1)  ·  Mark Layton, MD, MRCP (UK) (1)  ·  Maura Fallon (1)  ·  Rod Hepburn (1)  ·  William Fahy, MA, MBBS (Hons) (1)  ·  Zoltan Koroknai, MD, D.E.A.A. (1)

Results publications

PMID 22966146